| (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of RARA mRNA | CTD | PMID:12628509 |
| (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of RARA mRNA | CTD | PMID:12628509 PMID:20706672 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:11216 | 6480464 | Ethinyl Estradiol affects the expression of RARA mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:3534 | 6480464 | Ethinyl Estradiol affects the expression of RARA mRNA | CTD | PMID:16079270 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:11216 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RARA mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:11216 | 6480464 | Ethinyl Estradiol results in increased expression of RARA mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of RARA mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of RARA mRNA | CTD | PMID:23019147 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of RARA mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of RARA mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11216 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RARA mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11216 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RARA mRNA | CTD | PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RARA mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:11216 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RARA mRNA | CTD | PMID:17942748 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | ISO | RGD:3534 | 6480464 | Puromycin Aminonucleoside results in increased expression of RARA mRNA; more ... | CTD | PMID:12660332 |
| 4'-epidoxorubicin | affects mutagenesis | EXP | | 6480464 | Epirubicin affects the mutagenesis of RARA gene | CTD | PMID:19884644 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:11216 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of RARA mRNA | CTD | PMID:18648102 |
| 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid | multiple interactions | EXP | | 6480464 | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [arsenic trioxide results in increased degradation of RARA protein] | CTD | PMID:17018029 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | increases expression | EXP | | 6480464 | Am 580 results in increased expression of RARA protein | CTD | PMID:16636311 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | multiple interactions | EXP | | 6480464 | Am 580 binds to and results in increased activity of RARA protein | CTD | PMID:10779427 PMID:16178010 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | multiple interactions | EXP | | 6480464 | Am 580 binds to and results in increased activity of RARA protein | CTD | PMID:16178010 PMID:10779427 |
| 4-aminopyridine | multiple interactions | ISO | RGD:3534 | 6480464 | [Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]; more ... | CTD | PMID:15773917 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:11216 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of RARA mRNA | CTD | PMID:19191707 |
| 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of RARA protein | CTD | PMID:15375546 |
| 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of RARA mRNA | CTD | PMID:15735044 |
| 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | multiple interactions | EXP | | 6480464 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [TGFB1 protein results in increased expression of RARA mRNA] | CTD | PMID:8940178 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | decitabine promotes the reaction [vorinostat results in increased expression of RARA mRNA] | CTD | PMID:17417771 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [decitabine co-treated with Tretinoin] results in increased expression of RARA mRNA | CTD | PMID:19524134 |
| 8'-apo-beta,psi-caroten-8'-al | decreases expression | EXP | | 6480464 | apocarotenal results in decreased expression of RARA mRNA | CTD | PMID:17034753 |
| 9-cis-retinoic acid | multiple interactions | EXP | | 6480464 | alitretinoin promotes the reaction [RARA protein binds to PRAME protein] | CTD | PMID:16179254 |
| 9-cis-retinoic acid | increases expression | EXP | | 6480464 | alitretinoin results in increased expression of RARA mRNA | CTD | PMID:17034753 PMID:11139446 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:3534 | 6480464 | [Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]; more ... | CTD | PMID:15773917 |
| 9-cis-retinoic acid | increases expression | EXP | | 6480464 | alitretinoin results in increased expression of RARA mRNA | CTD | PMID:11139446 PMID:17034753 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:3534 | 6480464 | alitretinoin results in increased expression of RARA protein | CTD | PMID:16043492 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:11216 | 6480464 | alitretinoin results in increased expression of RARA mRNA | CTD | PMID:8892963 |
| 9-cis-retinoic acid | multiple interactions | EXP | | 6480464 | RARA protein promotes the reaction [alitretinoin results in increased expression of ABCC6 mRNA] | CTD | PMID:17045963 |
| 9-cis-retinoic acid | decreases expression | EXP | | 6480464 | alitretinoin results in decreased expression of RARA protein | CTD | PMID:15375546 |
| afimoxifene | multiple interactions | EXP | | 6480464 | 4-hydroxytamoxifen inhibits the reaction [Estrogens results in increased expression of RARA mRNA]; more ... | CTD | PMID:21233418 |
| alendronic acid | affects expression | ISO | RGD:3534 | 6480464 | Alendronate affects the expression of RARA mRNA | CTD | PMID:16079270 |
| all-trans-retinoic acid | affects binding | EXP | | 6480464 | Tretinoin binds to [RXRA protein binds to RARA protein]; more ... | CTD | PMID:16757381 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin results in increased ubiquitination of and results in increased degradation of RARA protein | CTD | PMID:15171703 PMID:20945414 |
| all-trans-retinoic acid | increases response to substance | EXP | | 6480464 | RARA protein results in increased susceptibility to Tretinoin | CTD | PMID:16287870 PMID:20945414 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tretinoin results in increased degradation of RARA protein] | CTD | PMID:20945414 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA protein | CTD | PMID:15171703 more ... |
| all-trans-retinoic acid | increases degradation | EXP | | 6480464 | Tretinoin results in increased degradation of RARA protein mutant form | CTD | PMID:15748426 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA mRNA | CTD | PMID:14592536 more ... |
| all-trans-retinoic acid | increases degradation | EXP | | 6480464 | Tretinoin results in increased degradation of RARA protein mutant form | CTD | PMID:19029980 more ... |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of RARA protein | CTD | PMID:15375546 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA mRNA | CTD | PMID:16766008 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA protein | CTD | PMID:16766008 more ... |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of RARA protein | CTD | PMID:16740359 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA mRNA | CTD | PMID:21393419 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA protein | CTD | PMID:16766008 more ... |
| all-trans-retinoic acid | increases degradation | EXP | | 6480464 | Tretinoin results in increased degradation of RARA protein mutant form | CTD | PMID:9834237 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA protein | CTD | PMID:15171703 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA mRNA | CTD | PMID:15171703 more ... |
| all-trans-retinoic acid | increases degradation | EXP | | 6480464 | Tretinoin results in increased degradation of RARA protein mutant form | CTD | PMID:15748426 more ... |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of RARA protein | CTD | PMID:16740359 more ... |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | azadirachtin inhibits the reaction [Tretinoin binds to and affects the localization of RARA protein] | CTD | PMID:21127062 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA protein | CTD | PMID:20507312 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA mRNA | CTD | PMID:16766008 more ... |
| all-trans-retinoic acid | increases degradation | EXP | | 6480464 | Tretinoin results in increased degradation of RARA protein mutant form | CTD | PMID:16352814 more ... |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of RARA protein | CTD | PMID:15171703 more ... |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:11216 | 6480464 | Tretinoin binds to and results in increased activity of RARA protein | CTD | PMID:16839186 PMID:12504905 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA protein | CTD | PMID:20507312 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA mRNA | CTD | PMID:21934132 more ... |
| all-trans-retinoic acid | increases degradation | EXP | | 6480464 | Tretinoin results in increased degradation of RARA protein mutant form | CTD | PMID:16352814 more ... |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin results in increased activity of [RARA protein binds to RXRA protein] | CTD | PMID:20008677 PMID:14592536 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of RARA protein | CTD | PMID:15194426 more ... |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of RARA mRNA alternative form] | CTD | PMID:16140955 |
| all-trans-retinoic acid | increases response to substance | EXP | | 6480464 | RARA protein results in increased susceptibility to Tretinoin | CTD | PMID:16287870 |
| all-trans-retinoic acid | affects localization | EXP | | 6480464 | Tretinoin affects the localization of RARA protein | CTD | PMID:16636311 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | RARA protein promotes the reaction [Tretinoin results in increased expression of VEGFA mRNA] | CTD | PMID:17170094 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | RARA protein promotes the reaction [Tretinoin results in increased activity of STS protein] | CTD | PMID:16178010 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [RARA protein binds to RXRA protein] promotes the reaction [Tretinoin results in increased degradation of NCOA3 protein]; more ... | CTD | PMID:16456540 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | RARA protein affects the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] | CTD | PMID:16194896 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Melatonin promotes the reaction [Tretinoin results in increased activity of RARA protein] | CTD | PMID:15813899 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | RARA protein affects the reaction [Tretinoin results in decreased secretion of IFNG protein]; more ... | CTD | PMID:16872382 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [PCNA protein binds to RARA protein] which affects the susceptibility to Tretinoin; more ... | CTD | PMID:16055921 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Melatonin co-treated with Tretinoin] results in increased activity of RARA protein | CTD | PMID:10965999 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Lipopolysaccharides promotes the reaction [Tretinoin results in increased expression of RARA mRNA]; more ... | CTD | PMID:17216566 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [decitabine co-treated with Tretinoin] results in increased expression of RARA mRNA | CTD | PMID:19524134 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | IFNG protein promotes the reaction [Tretinoin results in increased expression of RARA mRNA] | CTD | PMID:16007204 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | caffeic acid phenethyl ester promotes the reaction [Tretinoin results in increased activity of RARA protein]; more ... | CTD | PMID:16766008 |
| all-trans-retinoic acid | affects localization | ISO | RGD:3534 | 6480464 | Tretinoin affects the localization of RARA protein | CTD | PMID:17078027 |
| all-trans-retinoic acid | increases expression | ISO | RGD:3534 | 6480464 | Tretinoin results in increased expression of RARA protein | CTD | PMID:16043492 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:3534 | 6480464 | IL1B protein promotes the reaction [Tretinoin affects the localization of RARA protein] | CTD | PMID:17078027 |
| all-trans-retinoic acid | increases expression | ISO | RGD:11216 | 6480464 | Tretinoin results in increased expression of RARA mRNA | CTD | PMID:8892963 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:11216 | 6480464 | Tretinoin results in decreased expression of RARA protein | CTD | PMID:15646024 |
| all-trans-retinoic acid | affects binding | ISO | RGD:11216 | 6480464 | [Tretinoin binds to RARA protein] which binds to NRL promoter | CTD | PMID:16854989 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:11216 | 6480464 | Tretinoin binds to and results in increased activity of RARA protein | CTD | PMID:12504905 PMID:16839186 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:11216 | 6480464 | RARA protein inhibits the reaction [Tretinoin results in increased activity of [CLOCK protein binds to ARNTL protein]] | CTD | PMID:17069763 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:11216 | 6480464 | RARA protein affects the reaction [Tretinoin affects the expression of CYP26A1 mRNA]; more ... | CTD | PMID:16261163 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | ZNF366 protein promotes the reaction [Tretinoin results in increased activity of [RARA protein binds to RXRA protein]] | CTD | PMID:20008677 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin results in increased sumoylation of and results in decreased degradation of RARA protein; more ... | CTD | PMID:15171703 |
| all-trans-retinoic acid | increases phosphorylation | EXP | | 6480464 | Tretinoin results in increased phosphorylation of RARA protein mutant form | CTD | PMID:19029980 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA protein | CTD | PMID:15171703 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA mRNA alternative form | CTD | PMID:16140955 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin results in increased expression of and results in increased activity of RARA protein | CTD | PMID:16158052 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RARA mRNA | CTD | PMID:14592536 more ... |
| all-trans-retinoic acid | increases degradation | EXP | | 6480464 | Tretinoin results in increased degradation of RARA protein mutant form | CTD | PMID:9834237 more ... |
| all-trans-retinoic acid | increases degradation | EXP | | 6480464 | Tretinoin results in increased degradation of RARA protein | CTD | PMID:16456540 |
| all-trans-retinoic acid | increases cleavage | EXP | | 6480464 | Tretinoin results in increased cleavage of RARA protein mutant form | CTD | PMID:12130515 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin results in increased activity of [RARA protein binds to RXRA protein] | CTD | PMID:14592536 PMID:20008677 |
| all-trans-retinoic acid | increases activity | EXP | | 6480464 | Tretinoin results in increased activity of RARA protein | CTD | PMID:16766008 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of RARA protein | CTD | PMID:15375546 more ... |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [RARA protein binds to FOLR2 promoter] | CTD | PMID:16740727 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [RARA protein binds to PRAME protein] | CTD | PMID:16179254 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [[RARA protein binds to RXRA protein] which binds to NOS2A promoter] | CTD | PMID:17306764 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [RARA protein binds to CD1D promoter] | CTD | PMID:17392484 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [CREBBP protein binds to RARA protein] | CTD | PMID:16417649 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin inhibits the reaction [RARA protein mutant form results in decreased expression of SPI1 mRNA]; more ... | CTD | PMID:16352814 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin inhibits the reaction [CCNH protein binds to and results in increased phosphorylation of RARA protein mutant form] | CTD | PMID:16935935 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA | CTD | PMID:17244623 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin inhibits the reaction [BTG2 protein binds to RARA protein]; more ... | CTD | PMID:16782888 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with Butyrates] results in increased cleavage of RARA protein mutant form; more ... | CTD | PMID:12130515 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in decreased expression of RARA mRNA alternative form | CTD | PMID:19225113 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin binds to and affects the activity of RARA protein] which results in increased activity of CDKN1A protein | CTD | PMID:16765349 |
| all-trans-retinol | multiple interactions | EXP | | 6480464 | [Vitamin A co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA | CTD | PMID:17244623 |
| all-trans-retinol | increases expression | EXP | | 6480464 | Vitamin A results in increased expression of RARA mRNA | CTD | PMID:17034753 PMID:17225872 |
| all-trans-retinol | increases expression | ISO | RGD:3534 | 6480464 | Vitamin A deficiency results in increased expression of RARA mRNA | CTD | PMID:7519440 |
| all-trans-retinol | multiple interactions | ISO | RGD:11216 | 6480464 | [RARA gene mutant form co-treated with Vitamin A] results in decreased expression of COL2A1 mRNA; more ... | CTD | PMID:16397886 |
| all-trans-retinol | increases expression | EXP | | 6480464 | Vitamin A results in increased expression of RARA mRNA | CTD | PMID:17225872 PMID:17034753 |
| all-trans-retinyl palmitate | multiple interactions | ISO | RGD:3534 | 6480464 | retinol palmitate promotes the reaction [RARA protein binds to MMP9 protein] | CTD | PMID:17164434 |
| allethrin | increases activity | EXP | | 6480464 | Allethrin results in increased activity of RARA protein | CTD | PMID:20143881 |
| ammonium chloride | affects expression | ISO | RGD:3534 | 6480464 | Ammonium Chloride affects the expression of RARA mRNA | CTD | PMID:16483693 |
| azadirachtin A | multiple interactions | EXP | | 6480464 | azadirachtin inhibits the reaction [Tretinoin binds to and affects the localization of RARA protein] | CTD | PMID:21127062 |
| benzo[a]pyrene | decreases expression | ISO | RGD:11216 | 6480464 | Benzo(a)pyrene results in decreased expression of RARA mRNA | CTD | PMID:21803694 |
| benzo[a]pyrene | affects activity | EXP | | 6480464 | Benzo(a)pyrene affects the activity of RARA protein | CTD | PMID:20624995 |
| beta-carotene | decreases expression | EXP | | 6480464 | beta Carotene results in decreased expression of RARA mRNA | CTD | PMID:17034753 |
| bicuculline | multiple interactions | ISO | RGD:3534 | 6480464 | [Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [alitretinoin results in increased activity of RARA protein]; more ... | CTD | PMID:15773917 |
| bisphenol A | increases expression | ISO | RGD:11216 | 6480464 | bisphenol A results in increased expression of RARA mRNA | CTD | PMID:14967906 PMID:15738621 |
| bisphenol A | decreases expression | ISO | RGD:11216 | 6480464 | bisphenol A results in decreased expression of RARA mRNA | CTD | PMID:14967906 |
| bisphenol A | increases expression | ISO | RGD:11216 | 6480464 | bisphenol A results in increased expression of RARA mRNA | CTD | PMID:15738621 PMID:14967906 |
| buprofezin | increases activity | EXP | | 6480464 | buprofezin results in increased activity of RARA protein | CTD | PMID:20143881 |
| cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of RARA mRNA | CTD | PMID:21297354 |
| calciol | multiple interactions | EXP | | 6480464 | RARA protein mutant form inhibits the reaction [[Cholecalciferol co-treated with TGFB1 protein] results in increased expression of CD14 mRNA] | CTD | PMID:15988048 |
| calciol | multiple interactions | ISO | RGD:3534 | 6480464 | Cholecalciferol inhibits the reaction [Methylnitrosourea results in increased expression of RARA mRNA] | CTD | PMID:21843606 |
| carnosic acid | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with salvin] results in increased expression of RARA protein | CTD | PMID:11504768 |
| chlorogenic acid | increases expression | EXP | | 6480464 | Chlorogenic Acid results in increased expression of RARA mRNA | CTD | PMID:20706672 |
| chlorpromazine | decreases expression | ISO | RGD:3534 | 6480464 | Chlorpromazine results in decreased expression of RARA mRNA | CTD | PMID:18246545 |
| choline | multiple interactions | ISO | RGD:11216 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RARA gene | CTD | PMID:20938992 |
| cisplatin | increases expression | ISO | RGD:3534 | 6480464 | Cisplatin results in increased expression of RARA mRNA | CTD | PMID:18172885 |
| cobalt dichloride | multiple interactions | EXP | | 6480464 | cobaltous chloride promotes the reaction [arsenic trioxide results in increased degradation of RARA protein mutant form] | CTD | PMID:16330433 |
| coumaphos | increases activity | EXP | | 6480464 | Coumaphos results in increased activity of RARA protein | CTD | PMID:20143881 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [TGFB1 protein results in increased expression of RARA mRNA] | CTD | PMID:8940178 |
| cyclophosphamide | increases expression | ISO | RGD:3534 | 6480464 | Cyclophosphamide results in increased expression of RARA mRNA | CTD | PMID:16141653 |
| D-gluconic acid | multiple interactions | ISO | RGD:3534 | 6480464 | [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of RARA mRNA | CTD | PMID:16556975 |
| deoxycholic acid | multiple interactions | ISO | RGD:3534 | 6480464 | [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of RARA mRNA | CTD | PMID:16556975 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of RARA mRNA | CTD | PMID:19022236 |
| diarsenic trioxide | increases degradation | EXP | | 6480464 | arsenic trioxide results in increased degradation of RARA protein mutant form | CTD | PMID:17217047 more ... |
| diarsenic trioxide | increases degradation | EXP | | 6480464 | arsenic trioxide results in increased degradation of RARA protein | CTD | PMID:17018029 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [arsenic trioxide results in increased degradation of RARA protein] | CTD | PMID:17018029 |
| diarsenic trioxide | increases degradation | EXP | | 6480464 | arsenic trioxide results in increased degradation of RARA protein mutant form | CTD | PMID:15748426 more ... |
| diarsenic trioxide | increases degradation | EXP | | 6480464 | arsenic trioxide results in increased degradation of RARA protein mutant form | CTD | PMID:17217047 more ... |
| diarsenic trioxide | increases degradation | EXP | | 6480464 | arsenic trioxide results in increased degradation of RARA protein mutant form | CTD | PMID:15748426 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:11216 | 6480464 | arsenic trioxide results in increased degradation of and results in decreased expression of RARA protein | CTD | PMID:15688020 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | arsenic trioxide promotes the reaction [puerarin results in decreased expression of RARA mRNA alternative form] | CTD | PMID:20416161 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | cobaltous chloride promotes the reaction [arsenic trioxide results in increased degradation of RARA protein mutant form] | CTD | PMID:16330433 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in decreased expression of RARA mRNA alternative form | CTD | PMID:19225113 |
| diarsenic trioxide | increases degradation | EXP | | 6480464 | arsenic trioxide results in increased degradation of RARA protein mutant form | CTD | PMID:9834237 more ... |
| diarsenic trioxide | increases degradation | EXP | | 6480464 | arsenic trioxide results in increased degradation of RARA protein mutant form | CTD | PMID:16891316 more ... |
| dibutyl phthalate | decreases expression | ISO | RGD:11216 | 6480464 | Dibutyl Phthalate results in decreased expression of RARA mRNA | CTD | PMID:21266533 |
| dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | increases degradation | EXP | | 6480464 | Antimony Potassium Tartrate results in increased degradation of RARA protein mutant form | CTD | PMID:9834237 |
| fenofibrate | multiple interactions | ISO | RGD:3534 | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA | CTD | PMID:18253720 |
| folic acid | multiple interactions | ISO | RGD:11216 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RARA gene | CTD | PMID:20938992 |
| fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of RARA promoter | CTD | PMID:22847954 |
| furan | increases methylation | ISO | RGD:3534 | 6480464 | furan results in increased methylation of RARA gene | CTD | PMID:22079235 |
| gamma-hexachlorocyclohexane | increases activity | EXP | | 6480464 | Lindane results in increased activity of RARA protein | CTD | PMID:20143881 |
| griseofulvin | increases expression | ISO | RGD:11216 | 6480464 | Griseofulvin results in increased expression of RARA mRNA | CTD | PMID:9548566 |
| hydroxyurea | increases mutagenesis | ISO | RGD:11216 | 6480464 | Hydroxyurea results in increased mutagenesis of RARA gene | CTD | PMID:16868089 |
| isotretinoin | increases expression | EXP | | 6480464 | Isotretinoin results in increased expression of RARA mRNA | CTD | PMID:9262057 |
| isotretinoin | decreases expression | ISO | RGD:3534 | 6480464 | Isotretinoin results in decreased expression of RARA mRNA | CTD | PMID:19041696 |
| kojic acid | multiple interactions | ISO | RGD:3534 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA | CTD | PMID:18544905 |
| L-methionine | multiple interactions | ISO | RGD:11216 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RARA gene | CTD | PMID:20938992 |
| lead diacetate | decreases expression | ISO | RGD:11216 | 6480464 | lead acetate results in decreased expression of RARA mRNA | CTD | PMID:22609695 |
| limonene | decreases expression | ISO | RGD:3534 | 6480464 | limonene results in decreased expression of RARA mRNA | CTD | PMID:12815608 |
| melatonin | multiple interactions | EXP | | 6480464 | [Melatonin co-treated with Tretinoin] results in increased activity of RARA protein | CTD | PMID:10965999 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin promotes the reaction [Tretinoin results in increased activity of RARA protein] | CTD | PMID:15813899 |
| mercury atom | decreases expression | ISO | RGD:3534 | 6480464 | Mercury results in decreased expression of RARA mRNA | CTD | PMID:22688007 |
| mercury(0) | decreases expression | ISO | RGD:3534 | 6480464 | Mercury results in decreased expression of RARA mRNA | CTD | PMID:22688007 |
| methoxychlor | affects expression | ISO | RGD:11216 | 6480464 | Methoxychlor affects the expression of RARA mRNA | CTD | PMID:20829426 |
| mitoxantrone | affects mutagenesis | EXP | | 6480464 | Mitoxantrone affects the mutagenesis of RARA gene | CTD | PMID:19884644 |
| N-methyl-N-nitrosurea | increases mutagenesis | ISO | RGD:11216 | 6480464 | Methylnitrosourea results in increased mutagenesis of RARA gene | CTD | PMID:16868089 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:3534 | 6480464 | Methylnitrosourea results in increased expression of RARA mRNA | CTD | PMID:21843606 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:3534 | 6480464 | Cholecalciferol inhibits the reaction [Methylnitrosourea results in increased expression of RARA mRNA] | CTD | PMID:21843606 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:3534 | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA | CTD | PMID:18253720 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:3534 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA | CTD | PMID:18544905 |
| ochratoxin A | decreases expression | ISO | RGD:3534 | 6480464 | ochratoxin A results in decreased expression of RARA mRNA | CTD | PMID:23358140 |
| okadaic acid | multiple interactions | ISO | RGD:3534 | 6480464 | Okadaic Acid promotes the reaction [alitretinoin results in increased activity of RARA protein] | CTD | PMID:15773917 |
| parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of RARA promoter | CTD | PMID:22847954 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:3534 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of RARA mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:3534 | 6480464 | perfluorooctanoic acid results in decreased expression of RARA mRNA | CTD | PMID:19162173 |
| phenytoin | increases expression | ISO | RGD:11216 | 6480464 | Phenytoin results in increased expression of RARA mRNA | CTD | PMID:9988880 |
| phenytoin | decreases expression | ISO | RGD:11216 | 6480464 | Phenytoin results in decreased expression of RARA mRNA | CTD | PMID:9118846 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with salvin] results in increased expression of RARA protein | CTD | PMID:11504768 |
| phosalone | increases activity | EXP | | 6480464 | phosalone results in increased activity of RARA protein | CTD | PMID:20143881 |
| propiconazole | increases activity | EXP | | 6480464 | propiconazole results in increased activity of RARA protein | CTD | PMID:20143881 |
| raloxifene | affects expression | ISO | RGD:3534 | 6480464 | Raloxifene affects the expression of RARA mRNA | CTD | PMID:16079270 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of RARA mRNA | CTD | PMID:20706672 |
| sodium dodecyl sulfate | decreases expression | ISO | RGD:3534 | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of RARA mRNA | CTD | PMID:12815608 |
| tamibarotene | decreases response to substance | EXP | | 6480464 | RARA results in decreased susceptibility to Am 80; more ... | CTD | PMID:17611697 |
| tamibarotene | multiple interactions | EXP | | 6480464 | Am 80 inhibits the reaction [KLF5 protein binds to [RARA protein binds to RXRA protein]]; more ... | CTD | PMID:16224062 |
| tamibarotene | increases expression | ISO | RGD:3534 | 6480464 | Am 80 results in increased expression of RARA protein; more ... | CTD | PMID:19457078 |
| tamoxifen | affects expression | ISO | RGD:11216 | 6480464 | Tamoxifen affects the expression of RARA mRNA | CTD | PMID:17555576 |
| terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of RARA promoter | CTD | PMID:22847954 |
| testosterone | decreases expression | ISO | RGD:3534 | 6480464 | Testosterone results in decreased expression of RARA mRNA | CTD | PMID:16432891 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of RARA mRNA | CTD | PMID:20706672 |
| trichostatin A | multiple interactions | ISO | RGD:3534 | 6480464 | trichostatin A promotes the reaction [alitretinoin results in increased activity of RARA protein] | CTD | PMID:15773917 |
| troglitazone | multiple interactions | EXP | | 6480464 | [RARA gene mutant form co-treated with NPM1 gene mutant form] affects the susceptibility to troglitazone | CTD | PMID:14508522 |
| valproic acid | increases expression | ISO | RGD:11216 | 6480464 | Valproic Acid results in increased expression of RARA mRNA | CTD | PMID:15799026 |
| vanadyl sulfate | decreases expression | EXP | | 6480464 | vanadyl sulfate results in decreased expression of RARA mRNA | CTD | PMID:16330358 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of RARA protein mutant form | CTD | PMID:16330433 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of RARA mRNA | CTD | PMID:22171008 |
| zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of RARA mRNA | CTD | PMID:18593933 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of RARA protein mutant form | CTD | PMID:16330433 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of RARA mRNA | CTD | PMID:18593933 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of RARA mRNA | CTD | PMID:22171008 |